A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity

Toxicology and Applied Pharmacology

Volumn 167, Issue 3, 2000, Pages 182-190

  Taylor, M D ^a   Van Dyke, K ^a   Bowman, L L ^b   Miles, P R ^b   Hubbs, A F ^d   Mason, R J ^c   Shannon, K ^c   Reasor, M J ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d NONE

Author keywords

Amiodarone; Amiodarone induced pulmonary toxicity; Biomarker; Fibrosis; Inflammation; Surfactant protein D

Indexed keywords

ALBUMIN; AMIODARONE; BIOLOGICAL MARKER; NITRIC OXIDE; SUPEROXIDE; SURFACTANT PROTEIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EOSINOPHIL; HISTOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LUNG TOXICITY; MALE; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; RAT;

ANIMALIA;

EID: 0034665861     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.9000     Document Type: Article

References (41)

1. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients
2. Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism
3. Introduction of luminol-dependent chemiluminescence as a method to study silica inflammation in the tissue and phagocytic cells of rat lung
4. Class III antiarrhythmic agents: The next wave
5. Acute pulmonary inflammation in hamsters following intratracheal administration of amiodarone
6. Pulmonary responses to amiodarone in hamsters: Comparison of intratracheal and oral administrations
7. Computed tomography of amiodarone pulmonary toxicity
8. Amiodarone-induced pulmonary fibrosis in hamsters
9. Chronic amiodarone ingestion induces pulmonary toxicity in rats
10. Evidence-based analysis of amiodarone efficacy and safety
11. Structure, biologic properties, and expression of surfacrant protein D (SP-D)
12. Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone
13. Amiodarone pulmonary toxicity: Its radiological features
14. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity
15. Serum lactate dehydrogenase activity: Indicator of the development of pneumonitis induced by amiodarone [letter]
16. Pharmacology of the eosinophil
17. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS
18. Cellular and molecular regulation of eosinophil trafficking to the lung
19. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids
20. Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Consequences of drug accumulation on cellular lipid metabolism and plasma membrane properties of chronically exposed cells
21. Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy
22. Amiodarone causes acute oxidant lung injury in ventilated and perfused rabbit lungs
23. Surfactant proteins A and D: Disease markers
24. Macrophages and inflammatory mediators in tissue injury
25. Investigation of the role of oxidative stress in amiodarone-induced pulmonary toxicity in the hamster
26. Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug
27. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I)
28. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part II)
29. Amiodarone
30. Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity
31. The value of computed tomography in the diagnosis of amiodarone-induced pulmonary toxicity
32. Amiodarone pulmonary toxicity
33. Comparison of the in vivo pulmonary toxicity of amiodarone and des-oxo-amiodarone in the hamster
34. An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity
35. Amiodarone-induced pulmonary toxicity in Fischer rats: Release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages
36. Amiodarone-induced pulmonary fibrosis in Fischer 344 rats
37. Primary structure of rat pulmonary surfactant protein D. cDNA and deduced amino acid sequence
38. Macrophages and polymorphonuclear neutrophils in lung defense and injury
39. Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment
40. Side effects from amiodarone
41. The many faces of an increase in lung collagen